Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000117978 | SCV000229638 | benign | not specified | 2014-08-06 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000117978 | SCV000269699 | benign | not specified | 2015-01-13 | criteria provided, single submitter | clinical testing | p.Gly2812Gly in exon 32 of PLEC: This variant is not expected to have clinical s ignificance because it does not alter an amino acid residue and is not located w ithin the splice consensus sequence. It has been identified in 7.7% (656/8506) o f European American chromosomes from a broad population by the NHLBI Exome Seque ncing Project (http://evs.gs.washington.edu/EVS; dbSNP rs35139934). |
Prevention |
RCV000117978 | SCV000304350 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Athena Diagnostics | RCV000712762 | SCV000843286 | benign | not provided | 2018-06-21 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001521010 | SCV001730258 | benign | Epidermolysis bullosa simplex 5B, with muscular dystrophy; Epidermolysis bullosa simplex, Ogna type; Epidermolysis bullosa simplex 5C, with pyloric atresia; Autosomal recessive limb-girdle muscular dystrophy type 2Q; Epidermolysis bullosa simplex with nail dystrophy | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000712762 | SCV001837336 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000712762 | SCV005222301 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Genetic Services Laboratory, |
RCV000117978 | SCV000152290 | likely benign | not specified | no assertion criteria provided | clinical testing | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. |